BMO Capital Markets upgraded Intuitive Surgical (ISRG) to a strong-buy rating. The firm established a price target of $518 for the stock.
BMO analysts noted the MedTech sector currently trades significantly below its 10-year average. This valuation gap presents a buying opportunity for the dominant leader in the robotic-assisted surgery market.
Intuitive Surgical reported first-quarter 2026 results that exceeded estimates for revenue, earnings, and procedure volume. The company raised its full-year guidance following the report, despite a recent decline in its share price.